Century Therapeutics (IPSC) announced the appointments of Han Lee, Ph.D., M.B.A., and Martin Murphy, Ph.D., to its Board of Directors. As part of their appointments, Dr. Lee will serve as a member of the Audit and the Compensation Committees and Dr. Murphy will serve as a member of the Compensation and the Nominating and Corporate Governance Committees.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IPSC:
- Century Therapeutics downgraded to Market Perform from Outperform at Leerink
- Century Therapeutics Reports Positive Q3 2025 Earnings
- Century Therapeutics Launches Type 1 Diabetes Program
- Century Therapeutics reports Q3 EPS (40c) vs (37c) last year
- Century Therapeutics announces new beta islet program for Type 1 diabetes